Zoi Alexiou
Elefsina, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection.
Journal: Cell reports. Medicine
Published: March 30, 2025
Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial.
Journal: International journal of antimicrobial agents
Published: November 03, 2024
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.
Journal: International journal of antimicrobial agents
Published: April 10, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.
Journal: Critical care (London, England)
Published: January 11, 2024
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: July 28, 2023
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study.
Journal: Microorganisms
Published: April 30, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
Journal: EClinicalMedicine
Published: October 10, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Journal: Cytokine
Published: October 09, 2022
Last Updated: 09/26/2026